Clinical Trial 46497

Oceanside, CA 92056


We currently have Monotherapy and Adjunctive Schizophrenia studies that are enrolling for participants who have been on a stable Anti-psychotic medication for at least 3 weeks. )

Who is Qualified?:

  • Participants who are generally healthy and between 18-80 years old.
  • Participants who have been on an Anti-Psychotic medication for at least 3 weeks.
  • Must have a study partner who can make it to the first visit and be available by phone after.
  • Diagnosis of Schizophrenia at least 1 year.
  • Insurance not required to qualify.
  • Participants willing to stop current medication and replace it with study drug or add a medication to their current treatments.

Qualified Participants Can Receive:
  • $100 in Compensation after each completed in-person appointment and $50 for phone call visits.
  • Travel or gas reimbursement or a ride to visits after the first appointment is completed.
  • Investigational medications at no cost.
  • Free labs and blood work during the initial visit and through the study.

How long are these studies?
  • $Studies can last up to 1 year with as many as 20 visits. The shortest study will be 16 weeks with 7 visits at our office in Oceanside.
  • Studies are voluntary in the sense that you can stop at any moment; You are paid after each completed appointment along with reimbursed for travel.
  • Each visit will be about an hour besides the initial screening visit which is normally 4-5 hours.

Available At:

Excell Research
3998 Vista Way, Suite 100
Oceanside, CA 92056
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.